Moving avidence into action
This document is part of a series of briefs for health program managers interested in implementing evidence-based programs. With a special emphasis on underutilized interventions, they present evidence on programs that work and provide guidance and resources for replicat...ion.
more
HIV/TB Research Meeting; March 3, 2013
PLOS ONE | DOI:10.1371/journal.pone.0142290 November 9, 2015; 1 / 16
Review
S Afr Med J 2014;104(3):174-177. DOI: 10.7196/SAMJ.7968
Research
Emerging Infectious Diseases Vol. 12, No. 5, May 2006
Профілактичне лікування ізоніазидом. Що це таке?
PLoSONE 12(9):e0184986.https://doi.org/10.1371/journal.pone.0184986
PLOS ONE | DOI:10.1371/journal.pone.0155525 May 19, 2016, 1 / 11
Research Article
BMC Infectious Diseases 2014, 14:91/1471-2334/14/91
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evi...dence-based policies.
more
This study aimed to determine the drug resistance profile of Mycobacterium tuberculosis in Mozambique and concludes that M. tuberculosis resistance to antituberculosis drugs is high in Mozambique, especially in previously treated patients. The frequency of M. tuberculosis strains that were resistant... to isoniazid, rifampin, and streptomycin in combination was found to be high, particularly in samples from previously treated patients.
J Bras Pneumol. 2014;40(2):142-147
more
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for is...oniazid-resistant TB (Hr-TB) and MDR/RR-TB, including longer and shorter regimens, culture monitoring of patients on treatment, the timing of antiretroviral therapy (ART) in MDR/RR-TB patients infected with the human immunodeficiency virus (HIV), use of surgery for patients receiving MDR-TB treatment, and optimal models of patient support and care.
more